Trichloroethylene and Parkinson's Disease: Dissolving the Puzzle
Overview
Pharmacology
Authors
Affiliations
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
Ilieva N, Hoffman E, Ghalib M, Greenamyre J, De Miranda B Neurobiol Dis. 2024; 196:106522.
PMID: 38705492 PMC: 11332574. DOI: 10.1016/j.nbd.2024.106522.
Association Study Between Kynurenine 3-Monooxygenase (KMO) Gene and Parkinson's Disease Patients.
Babu H, Elangovan A, Iyer M, Kirola L, Muthusamy S, Jeeth P Mol Neurobiol. 2023; 61(7):3867-3881.
PMID: 38040995 DOI: 10.1007/s12035-023-03815-9.
Shreevatsa B, Dharmashekara C, Jain A, Amachawadi R, Achar R, Syed A J Mol Model. 2022; 28(8):209.
PMID: 35789297 DOI: 10.1007/s00894-022-05176-x.
Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.
El-Gamal M, Salama M, Collins-Praino L, Baetu I, Fathalla A, Soliman A Neurotox Res. 2021; 39(3):897-923.
PMID: 33765237 DOI: 10.1007/s12640-021-00356-8.
Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA.
Gomes F, Flores R, Bruxel M, da Silva F, Moreira E, Zoccal D Front Neurosci. 2019; 12:1020.
PMID: 30686986 PMC: 6333712. DOI: 10.3389/fnins.2018.01020.